Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.
about
Fingolimod for relapsing-remitting multiple sclerosisThe Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-AnalysisCentral Atrophy Early in Multiple Sclerosis: Third Ventricle Volumetry versus Planimetry.A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis.Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimodTime course of glatiramer acetate efficacy in patients with RRMS in the GALA study.Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy.Synthetic MRI in the Detection of Multiple Sclerosis Plaques.A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis.
P2860
Q24185882-581FF78A-9D3C-45B3-A5D5-5786D06DC151Q26773978-39367DB1-E70B-4BFC-ABAD-6ED218739553Q30395772-9198CF40-6D5B-4720-A9E0-756421319CE3Q33742905-50EC3D0A-0C09-4F2A-9E63-18425B016A32Q36097847-AC7DC128-7DDD-4E2E-8AD5-A18439832BC9Q37633582-4E7BA621-A854-4D9B-ABAC-764EF0146635Q38619288-817B675D-9688-4245-A79A-5480A9F23D08Q38632074-917AEC5F-9D2C-45C6-B810-1FE921F9EC66Q39118004-CB457C80-9659-4456-8A71-35ABF70522D2Q47563453-885DEC70-D1D4-4C92-A8DB-3DEFB4C3CC31
P2860
Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Outcome measures in relapsing- ...... rogression in clinical trials.
@ast
Outcome measures in relapsing- ...... rogression in clinical trials.
@en
type
label
Outcome measures in relapsing- ...... rogression in clinical trials.
@ast
Outcome measures in relapsing- ...... rogression in clinical trials.
@en
prefLabel
Outcome measures in relapsing- ...... rogression in clinical trials.
@ast
Outcome measures in relapsing- ...... rogression in clinical trials.
@en
P2093
P2860
P921
P356
P1476
Outcome measures in relapsing- ...... rogression in clinical trials.
@en
P2093
Amy M Lavery
Amy T Waldman
Leonard H Verhey
P2860
P304
P356
10.1155/2014/262350
P577
2014-05-04T00:00:00Z